WebSleepiness and dizziness are possible side effects of oxcarbazepine (Trileptal). Don't drive or do anything that requires you to be alert until you know how oxcarbazepine (Trileptal) affects you. Drinking alcohol raises the risk of these side effects, so it's best to avoid drinking alcohol while taking this medication. WebJan 23, 2024 · Common side effects may include: dizziness, drowsiness, tiredness, weakness; feeling aggressive or irritable; loss of appetite; stuffy nose; or. infection. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Trileptal (Oxcarbazepine) - Warnings and Precautions - Druglib.com
WebWARNINGS AND PRECAUTIONS . Hyponatremia . Measurement of serum sodium levels should be considered for patients during maintenance treatment with Trileptal, particularly if the patient is receiving other medications known to decrease serum sodium levels (for example, drugs associated with inappropriate ADH secretion) or if symptoms possibly … WebJan 5, 2024 · trouble breathing; headache; nausea; or. feeling weak or tired. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at … bridal hair accessories kop mall
Oxcarbazepine: MedlinePlus Drug Information
WebDec 1, 2024 · Trileptal 300 mg_REG SPC_PF 20-0173_March 2024_IPHA_1617959361.pdf. Reasons for updating. Change to section 4.4 - Special warnings and precautions for use ; ... In Section 4.4 Special warnings and precautions for use. … WebFind patient medical information for Trileptal oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Webpopulations (see WARNINGS AND PRECAUTIONS - Ancestry and Allelic Variations in the HLA-B Gene). Until further information is available, the use of TRILEPTAL and other anti-epileptic drugs associated with SJS/TEN should be avoided in patients who test positive for the HLA-B*1502 allele. There are insufficient data to support a can the beneficiary of a will be a witness